Back to Journals » International Journal of General Medicine » Volume 16

KIF20A is a Prognostic Marker for Female Patients with Estrogen Receptor-Positive Breast Cancer and Receiving Tamoxifen as Adjuvant Endocrine Therapy

Total article views   HTML views PDF downloads Totals
1,843 Dovepress* 1,761+ 42 1,803
PubMed Central* 82 46 128
Totals 1,843 88 1,931
*Since 21 August 2023

View citations on PubMed Central and Google Scholar